PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

49 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
41.
Stefan, N. ; Häring, H.-U. ; Hu, F.B.* & Schulze, M.B.*: Divergent associations of height with cardiometabolic disease and cancer: Epidemiology, pathophysiology, and global implications. Lancet Diabet. Endocrinol. 4, 457-467 (2016)
42.
Stefan, N. ; Fritsche, A. ; Schick, F. & Häring, H.-U.: Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabet. Endocrinol. 4, 789-798 (2016)
43.
Interleukin 1 Genetics Consortium et al.: Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: A mendelian randomisation analysis. Lancet Diabet. Endocrinol. 3, 243-253 (2015)
44.
Chambers, J.C.* et al.: Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: A nested case-control study. Lancet Diabet. Endocrinol. 3, 526-534 (2015)
45.
NCD Risk Factors Collaboration (Müller-Nurasyid, M. ; Peters, A. ; Stöckl, D. ; Ezzati, M.*): Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants. Lancet Diabet. Endocrinol. 3, 624-637 (2015)
46.
Schmid, S.M.* ; Hallschmid, M. & Schultes, B.*: The metabolic burden of sleep loss. Lancet Diabet. Endocrinol. 3, 52-62 (2015)
47.
Stefan, N.* et al.: Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet Diabet. Endocrinol. 2, 406-416 (2014)
48.
Vimaleswaran, K.S.* et al.: Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study. Lancet Diabet. Endocrinol. 2, 719-729 (2014)
49.
Stefan, N. ; Häring, H.-U. ; Hu, F.B.* & Schulze, M.B.: Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications. Lancet Diabet. Endocrinol. 1, 152-162 (2013)